News
CMND
0.8200
-28.07%
-0.3200
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 11h ago
Dow Gains Over 200 Points; US Retail Sales Top Estimates
Benzinga · 14h ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 16h ago
Clearmind Medicine issues $2.7 million convertible notes at 90% of face value
PUBT · 17h ago
Clearmind Medicine Welcomes Executive Order On Psychedelic Therapies
NASDAQ · 1d ago
Clearmind Medicine issues $2.7 million convertible notes at 10% discount
PUBT · 1d ago
Clearmind welcomes Trump executive order speeding FDA review of breakthrough psychedelic therapies
PUBT · 1d ago
Crude Oil Surges Over 6%; Investar Holding Shares Gain Following Q1 Earnings
Benzinga · 1d ago
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 1d ago
Midday Fly By: QXO to acquire TopBuild, Lilly to buy Kelonia
TipRanks · 1d ago
US Stocks Mixed; Cleveland-Cliffs Shares Fall After Q1 Results
Benzinga · 1d ago
Why Is Clearmind Stock Rising Monday?
Benzinga · 1d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 1d ago
Market-Moving News for April 20th
Benzinga · 1d ago
Clearmind Medicine Says CMND-100, Proprietary Non-Hallucinogenic MEAI-Based Oral Drug Candidate, For Treatment Of AUD Met Primary Endpoint In Its FDA-Approved Phase I/IIa Clinical Trial
Benzinga · 1d ago
Clearmind says CMND-100 meets primary safety endpoint in AUD Phase I/IIa trial
PUBT · 1d ago
CLEARMIND MEDICINE INC - CMND-100 SHOWS HIGH SAFETY PROFILE AT HIGHEST DOSAGE WITH NO SERIOUS ADVERSE EVENTS
Reuters · 1d ago
Weekly Report: what happened at CMND last week (0413-0417)?
Weekly Report · 1d ago
Why TopBuild Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket
Benzinga · 1d ago
Clearmind Medicine Announced Positive Top-Line Safety Results: CMND-100 Proprietary Psychedelic Treatment Meets Primary Endpoint in AUD Trial
Barchart · 1d ago
More
Webull provides a variety of real-time CMND stock news. You can receive the latest news about Clearmind Medici through multiple platforms. This information may help you make smarter investment decisions.
About CMND
Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.